CINCINNATI, July 28 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL - News), a leading, global full-service clinical research organization, today announced the realignment of its C-suite to strengthen its competitive position and position the Company for continued growth as a top-tier global CRO. The creation of a new Chief Administrative Officer (CAO) role within Kendle's C-suite and executive leadership team as part of this realignment provides dedicated leadership for strategic technology and infrastructure enhancement initiatives to drive down overhead and deliver increased innovation, productivity and organizational efficiency, strengthening the Company's ability to deliver strategic outsourcing solutions for its global biopharmaceutical customers.
